Zobrazeno 11 - 15
of 15
pro vyhledávání: '"Guié MA"'
Autor:
McCloskey K; Google Research Applied Science, Mountain View, California 94043, United States., Sigel EA; X-Chem, Waltham, Massachusetts 02453, United States., Kearnes S; Google Research Applied Science, Mountain View, California 94043, United States., Xue L; X-Chem, Waltham, Massachusetts 02453, United States., Tian X; X-Chem, Waltham, Massachusetts 02453, United States., Moccia D; X-Chem, Waltham, Massachusetts 02453, United States.; Cognitive Dataworks, Amesbury, Massachusetts 01913, United States., Gikunju D; X-Chem, Waltham, Massachusetts 02453, United States., Bazzaz S; X-Chem, Waltham, Massachusetts 02453, United States., Chan B; X-Chem, Waltham, Massachusetts 02453, United States., Clark MA; X-Chem, Waltham, Massachusetts 02453, United States., Cuozzo JW; X-Chem, Waltham, Massachusetts 02453, United States., Guié MA; X-Chem, Waltham, Massachusetts 02453, United States., Guilinger JP; X-Chem, Waltham, Massachusetts 02453, United States., Huguet C; X-Chem, Waltham, Massachusetts 02453, United States., Hupp CD; X-Chem, Waltham, Massachusetts 02453, United States., Keefe AD; X-Chem, Waltham, Massachusetts 02453, United States., Mulhern CJ; X-Chem, Waltham, Massachusetts 02453, United States., Zhang Y; X-Chem, Waltham, Massachusetts 02453, United States., Riley P; Google Research Applied Science, Mountain View, California 94043, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Aug 27; Vol. 63 (16), pp. 8857-8866. Date of Electronic Publication: 2020 Jun 11.
Autor:
Litovchick A; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. alitovchick@x-chemrx.com., Tian X; Arrakis Therapeutics, Waltham, MA 02451, USA. xia2tian@hotmail.com., Monteiro MI; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. mmonteiro@x-chemrx.com., Kennedy KM; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. Kaitlyn.kennedy1288@gmail.com., Guié MA; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. mguie@x-chemrx.com., Centrella P; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. pcentrella@x-chemrx.com., Zhang Y; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. yzhang@x-chemrx.com., Clark MA; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. mclark@x-chemrx.com., Keefe AD; X-Chem Pharmaceuticals, Waltham, MA 02435, USA. akeefe@x-chemrx.com.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2019 May 27; Vol. 24 (10). Date of Electronic Publication: 2019 May 27.
Autor:
Brown DG; 1 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Waltham, MA, USA., Brown GA; 2 Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK., Centrella P; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Certel K; 3 X-Chem Pharmaceuticals, Waltham, MA, USA.; 5 Novartis Institute for BioMedical Research, Cambridge, MA, USA., Cooke RM; 2 Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK., Cuozzo JW; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Dekker N; 4 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Mölndal, Sweden., Dumelin CE; 3 X-Chem Pharmaceuticals, Waltham, MA, USA.; 6 Novartis Institute for BioMedical Research, Basel, Switzerland., Ferguson A; 1 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Waltham, MA, USA.; 7 X-Chem, Inc., Waltham, MA, USA., Fiez-Vandal C; 2 Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK., Geschwindner S; 4 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Mölndal, Sweden., Guié MA; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Habeshian S; 3 X-Chem Pharmaceuticals, Waltham, MA, USA.; 8 École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Keefe AD; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Schlenker O; 2 Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK., Sigel EA; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Snijder A; 4 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Mölndal, Sweden., Soutter HT; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Sundström L; 4 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Mölndal, Sweden., Troast DM; 3 X-Chem Pharmaceuticals, Waltham, MA, USA.; 9 Morphic Therapeutic, Waltham, MA., Wiggin G; 2 Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK., Zhang J; 1 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Waltham, MA, USA.; 10 Entasis Therapeutics, Waltham, MA., Zhang Y; 3 X-Chem Pharmaceuticals, Waltham, MA, USA., Clark MA; 3 X-Chem Pharmaceuticals, Waltham, MA, USA.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2018 Jun; Vol. 23 (5), pp. 429-436. Date of Electronic Publication: 2018 Jan 09.
Autor:
Litovchick A; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Dumelin CE; Novartis Pharma AG, Institutes of Biomedical Research, Basel, Switzerland., Habeshian S; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Gikunju D; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Guié MA; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Centrella P; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Zhang Y; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Sigel EA; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Cuozzo JW; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Keefe AD; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA., Clark MA; X-Chem Pharmaceuticals, 100 Beaver St., Waltham, MA, USA.
Publikováno v:
Scientific reports [Sci Rep] 2015 Jun 10; Vol. 5, pp. 10916. Date of Electronic Publication: 2015 Jun 10.
Autor:
Goldman RC; Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Division of AIDS, Therapeutics Research Program, Complications and Coinfections Research Branch, Bethesda, Maryland 20892, USA. rgoldman@niaid.nih.gov, Laughon BE, Reynolds RC, Secrist JA 3rd, Maddry JA, Guié MA, Poffenberger AC, Kwong CA, Ananthan S
Publikováno v:
Infectious disorders drug targets [Infect Disord Drug Targets] 2007 Jun; Vol. 7 (2), pp. 92-104.
- [1]
- « Předchozí
- 1
- 2